{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:40:11Z","timestamp":1762429211823},"reference-count":31,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2015]]},"DOI":"10.7883\/yoken.jjid.2013.190","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T23:30:09Z","timestamp":1416871809000},"page":"5-12","source":"Crossref","is-referenced-by-count":10,"title":["Polymorphisms of the ApoE (Apolipoprotein E) Gene and Their Influence on Dyslipidemia in HIV-1-Infected Individuals"],"prefix":"10.7883","volume":"68","author":[{"given":"Tanida","family":"Suwalak","sequence":"first","affiliation":[{"name":"Division of Clinical Chemistry, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"},{"name":"Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornpen","family":"Srisawasdi","sequence":"additional","affiliation":[{"name":"Division of Clinical Chemistry, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichaya","family":"Puangpetch","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siwalee","family":"Santon","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napatrupron","family":"Koomdee","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montri","family":"Chamnanphon","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angkana","family":"Charoenyingwattana","sequence":"additional","affiliation":[{"name":"Thailand Center of Excellence for Life Sciences, Ministry of Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasun","family":"Chantratita","sequence":"additional","affiliation":[{"name":"Division of Virology, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[{"name":"Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338:853-60.","DOI":"10.1056\/NEJM199803263381301"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet. 2003;362:22-9.","DOI":"10.1016\/S0140-6736(03)13802-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Koczor CA, Lewis W. Nucleoside reverse transcriptase inhibitor toxicity andmitochondrial DNA. Expert Opin Drug Metab Toxicol. 2010;6:1493-504.","DOI":"10.1517\/17425255.2010.526602"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Villarroya F, Domingo P, Giralt M. Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment. Biochim Biophys Acta. 2010;1801:392-9.","DOI":"10.1016\/j.bbalip.2009.09.018"},{"key":"5","unstructured":"5. Guaraldi G, Murri R, Orlando G, et al. Lipodystrophy and quality of life of HIV-infected persons. AIDS Rev. 2008;10:152-61."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS. 1999;13:2493-505.","DOI":"10.1097\/00002030-199912240-00002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wangsomboonsiri W, Mahasirimongkol S, Chantarangsu S, et al. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen. Clin Infect Dis. 2010;50:597-604.","DOI":"10.1086\/650003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Maher B, Alfirevic A, Vilar FJ. TNF-&alpha; promoter region gene polymorphisms in HIV-positive patients with lipodystrophy. AIDS. 2002;16:2013-8.","DOI":"10.1097\/00002030-200210180-00005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nolan D, Moore C, Castley A, et al. Tumour necrosis factor-alpha gene 238G\/A promoter polymorphism associated with a more rapid onset of lipodystrophy. AIDS. 2003;17:121-3.","DOI":"10.1097\/00002030-200301030-00017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tarr PE, Taff&eacute; P, Bleiber G, et al. Modeling the influence of <i>APOC3<\/i>, <i>APOE<\/i>, and <i>TNF<\/i> polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. J Infect Dis. 2005;191:1419-26.","DOI":"10.1086\/429295"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bonnet E, Bernard J, Fauvel J, et al. Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients. AIDS Res Hum Retroviruses. 2008;24:169-71.","DOI":"10.1089\/aid.2007.0076"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Miserez AR, Muller PY, Barella L, et al. A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia. AIDS. 2001;15:2045-9.","DOI":"10.1097\/00002030-200110190-00020"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Likanonsakul S, Rattanatham T, Feangvad S, et al. Polymorphisms in <i>Fas<\/i> gene is associated with HIV-related lipoatrophy in Thai patients. AIDS Res Hum Retroviruses. 2013;29:142-50.","DOI":"10.1089\/aid.2012.0114"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kuusisto J, Mykk&auml;nen L, Kervinen K, et al. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-6.","DOI":"10.1161\/01.ATV.15.9.1280"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pablos-M&eacute;ndez A, Mayeux R, Ngai C, et al. Association of apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol. 1997;17:3534-41.","DOI":"10.1161\/01.ATV.17.12.3534"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanguturi P, Pullareddy B, Kumar PS, et al. Association between apolipoprotein E gene polymorphism and myocardial infarction. Biochem Genet. 2013;51:398-405.","DOI":"10.1007\/s10528-013-9572-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res. 1992;33:447-54.","DOI":"10.1016\/S0022-2275(20)41611-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Marzocchetti A, Schwarz J, Di Giambenedetto S, et al. The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy. AIDS Res Hum Retroviruses. 2011;27:1299-1309.","DOI":"10.1089\/aid.2010.0172"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chantarangsu S, Mushiroda T, Mahasirimongkol S, et al. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Pharmacogenet Genomics. 2009;19:139-46.","DOI":"10.1097\/FPC.0b013e32831d0faf"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kiertiburanakul S, Sungkanuparph S, Charoenyingwattana A, et al. Risk factors for nevirapine-associated rash among HIV- infected patients with low CD4 cell counts in resource-limited settings. Curr HIV Res. 2008;6:65-9.","DOI":"10.2174\/157016208783571946"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Srisawasdi P, Suwalak T, Sukasem C, et al. Small-dense LDL cholesterol\/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients. Am J Clin Pathol. 2013;140:506-15.","DOI":"10.1309\/AJCPE5I3KELTBXEJ"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Carr A, Law M. HIV lipodystrophy case definition study group. An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr. 2003;33:571-6.","DOI":"10.1097\/00126334-200308150-00004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389-98.","DOI":"10.1097\/00002030-200107270-00008"},{"key":"24","unstructured":"24. WHO Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ. 1986;64:929-41."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Carr A, Emery S, Law M, et al. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003;361:726-35.","DOI":"10.1016\/S0140-6736(03)12656-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Marcovina S, Packard CJ. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med. 2006;259:437-46.","DOI":"10.1111\/j.1365-2796.2006.01648.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. de Carvalho EH, Miranda Filho Dde B, Ximenes RA, et al. Prevalence of hyperapolipoprotein B and associations with other cardiovascular risk factors among human immunodeficiency virus-infected patients in Pernambuco, Brazil. Metab Syndr Relat Disord. 2010;8:403-10.","DOI":"10.1089\/met.2009.0092"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Petit JM, Duong M, Florentin E, et al. Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study. J Lipid Res. 2003;44:1692-7.","DOI":"10.1194\/jlr.M300041-JLR200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mahley RW, Rall SC Jr. Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507-37.","DOI":"10.1146\/annurev.genom.1.1.507"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160-5.","DOI":"10.1016\/0002-9149(93)90732-R"},{"key":"31","unstructured":"31. Heide S, Manfred K, Gl&auml;ser C, et al. Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis? Forensic Sci Int. 2009;192:62-6."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T05:16:44Z","timestamp":1650691004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/68\/1\/68_JJID.2013.190\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2013.190","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}